Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy
Open Access
- 1 June 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (11)
Abstract
Renal osteodystrophy (ROD) is a disorder of bone metabolism that affects virtually all patients with chronic kidney disease (CKD) and is associated with adverse clinical outcomes including fractures, cardiovascular events, and death. In this study, we showed that hepatocyte nuclear factor 4α (HNF4α), a transcription factor mostly expressed in the liver, is also expressed in bone, and that osseous HNF4α expression was dramatically reduced in patients and mice with ROD. Osteoblast-specific deletion of Hnf4α resulted in impaired osteogenesis in cells and mice. Using multi-omics analyses of bones and cells lacking or overexpressing Hnf4α1 and Hnf4α2, we showed that HNF4α2 is the main osseous Hnf4α isoform that regulates osteogenesis, cell metabolism, and cell death. As a result, osteoblast-specific overexpression of Hnf4α2 prevented bone loss in mice with CKD. Our results showed that HNF4α2 is a transcriptional regulator of osteogenesis, implicated in the development of ROD.Keywords
Funding Information
- NIH/NIDDK (R01DK102815)
- NIH/NIDDK (R01DK114158)
- NIH/NIDDK (R01DK101730)
- NIH/NIDDK (R01DK131046)
- NIH/NIDDK (R56DK127986)
This publication has 86 references indexed in Scilit:
- Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult MiceJournal of Biological Chemistry, 2012
- Genome-wide association of an integrated osteoporosis-related phenotype: Is there evidence for pleiotropic genes?Journal of Bone and Mineral Research, 2011
- Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney diseaseJournal of Bone and Mineral Research, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- A role for coding functional variants in HNF4A in type 2 diabetes susceptibilityDiabetologia, 2010
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney diseaseBone, 2009
- Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor κB pathwayBiochemical Journal, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesisNature Genetics, 2003